222 related articles for article (PubMed ID: 8504466)
1. Depletion of O6-methylguanine-DNA methyltransferase and potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea antitumor activity by O6-benzylguanine in vitro.
Chen JM; Zhang YP; Moschel RC; Ikenaga M
Carcinogenesis; 1993 May; 14(5):1057-60. PubMed ID: 8504466
[TBL] [Abstract][Full Text] [Related]
2. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
3. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea resistance by O6-benzylguanine in vitro and in vivo.
Chen JM; Zhang YP; Sui JL; Moschel RC; Ikenaga M
Anticancer Res; 1993; 13(3):801-5. PubMed ID: 8317915
[TBL] [Abstract][Full Text] [Related]
4. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
Marathi UK; Kroes RA; Dolan ME; Erickson LC
Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924
[TBL] [Abstract][Full Text] [Related]
5. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.
Loktionova NA; Pegg AE
Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines. Effect of metabolism.
Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
Cancer Chemother Pharmacol; 2000; 45(1):69-77. PubMed ID: 10647505
[TBL] [Abstract][Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
9. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Felker GM; Friedman HS; Dolan ME; Moschel RC; Schold C
Cancer Chemother Pharmacol; 1993; 32(6):471-6. PubMed ID: 8258196
[TBL] [Abstract][Full Text] [Related]
10. Enhancement effect of O6-fluorobenzylguanines on chloroethylnitrosourea cytotoxicity in tumor cells.
Mineura K; Fukuchi M; Kowada M; Hitomi K; Terashima I; Kohda K
Life Sci; 1996; 58(19):PL303-8. PubMed ID: 8632694
[TBL] [Abstract][Full Text] [Related]
11. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
[TBL] [Abstract][Full Text] [Related]
12. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea.
Srivenugopal KS; Yuan XH; Friedman HS; Ali-Osman F
Biochemistry; 1996 Jan; 35(4):1328-34. PubMed ID: 8573590
[TBL] [Abstract][Full Text] [Related]
14. Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.
Dolan ME; Pegg AE; Biser ND; Moschel RC; English HF
Cancer Chemother Pharmacol; 1993; 32(3):221-5. PubMed ID: 8500228
[TBL] [Abstract][Full Text] [Related]
15. Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo.
Marathi UK; Dolan ME; Erickson LC
Biochem Pharmacol; 1994 Nov; 48(11):2127-34. PubMed ID: 7802703
[TBL] [Abstract][Full Text] [Related]
16. Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
Dolan ME; Pegg AE; Moschel RC; Grindey GB
Biochem Pharmacol; 1993 Jul; 46(2):285-90. PubMed ID: 8347150
[TBL] [Abstract][Full Text] [Related]
17. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
[TBL] [Abstract][Full Text] [Related]
18. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
Mitchell RB; Moschel RC; Dolan ME
Cancer Res; 1992 Mar; 52(5):1171-5. PubMed ID: 1737376
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of human and mouse alkyltransferase to O6-benzylguanine using a transgenic model.
Liu L; Lee K; Wasan E; Gerson SL
Cancer Res; 1996 Apr; 56(8):1880-5. PubMed ID: 8620508
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
